Global Point-of-Care Testing Market is Expected to Reach $35.3 billion by 2024 With Growing CAGR +9.5%| Research Analysis, Trend, Forecast, Growth Analysis, Competitors Analysis

Avail 10% Discount on Direct Purchase "Global Point-of-Care Testing Market" Or kindly send the email at sopan.gedam@databridgemarketresearch.com

Data Bridge Market Research new Insight’s on “Global Point-of-Care Testing (POCT) Market is projected to reach 38.2 billion by 2024, from USD 18.5 billion in 2016 growing at a CAGR of 9.5% during the forecast period of 2017 to 2024”.

The actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024.

Click Here For Free Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

Some Key Players:

Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, Inc, bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedicaamong others holds 53.1% of the global injectable drug delivery market in 2016.

F. HOFFMANN-LA ROCHE LTD:

Historical Background – Roche was established in 1896
Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.

Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.
Main Business Areas: Pharmaceuticals and Diagnostics.

Recent Developments:

1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

Inquire before buying @: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

Global Point-of-Care Testing (POCT) Market: Recent Developments

The demand for point-of-care testing (POCT) is growing due to the value-shift in healthcare and increasing technological advancements. Also, the rising prevalence of lifestyle and infectious diseases, early detection of diseases, and management of multiple chronic conditions is fueling the growth of the market. Some of the other factors contributing to the growth of the market are Private investments and venture funding, new product development and government support, increasing adoption of POC devices, and miniaturization of devices. On the other hand, factors such as pricing pressure, low reimbursement, and XX are restraining the growth of the market.

Factors such as emerging market, growing patient pool, rising number of partnerships and joint ventures, and rising initiatives by the market players will contribute to the growth of the market in future. Also, the current focus of the companies on the development of devices for diagnosis and treatment of cancer, stroke, and cardiac patients will drive the market in future. To compete with other POCT companies in the future, POCT companies will need to employ a different set of digital strategies and connectivity solutions.

Global Point-of-Care Testing (POCT) Market @: Geographic Segmentation

The global point-of-care testing market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For instance, in June 2015, Roche launched its Cardiac point-of-care (POC) troponin test for the cobas h 232 system which is available for countries which accept the CE Mark. This product has improved accuracy at low concentrations and it will help in diagnosis of heart attack patients with high mortality risk. The report includes company share data for different geographies including Global, North America, Europe and APAC.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Any specific requirements are you looking for? Ask to your Industry Experts: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=point-care-testing-poct-market

Other Market Insights:

The Global Molecular Spectroscopy Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 5.0% in the forecast period 2017 to 2024, expected to reach USD 6.712 Billion by 2024.

Report Access : http://databridgemarketresearch.com/reports/global-molecular-spectroscopy-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.